Fingolimod (FTY720) reduces viability and survival and increases histone H3 acetylation in medulloblastoma cells

.

Source: Pediatric Hematology and Oncology - December 19, 2019 Category: Pediatrics Authors: Alexandre S. Perla L ívia Fratini Paula S. Cardoso Caroline Brunetto de Farias Mariane da Cunha Jaeger Rafael Roesler Source Type: research